KeraVision corneal ring myopia study finds vision of at least 20/40 in 85% of patients -- IPO.
This article was originally published in The Gray Sheet
Executive Summary
KERAVISION ICR INTRASTROMAL CORNEAL RING PHASE II MYOPIA STUDY has found vision improvement to 20/40 or better among 85% of patients with six-month or longer follow-up, the firm reports in a June 5 registration statement with the Securities and Exchange Commission for an initial public offering. "As of their most recent examinations," the filing states, "85% of the 82 patients with the corneal ring had uncorrected visual acuity of 20/40 or better, the legal requirement in most states to obtain a driver's license without corrective lenses." With the addition of corrective lenses, one patient had vision of 20/25 and the remainder had 20/20 or better.